Helen Van Miegroet

413 total citations
8 papers, 314 citations indexed

About

Helen Van Miegroet is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Helen Van Miegroet has authored 8 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in Helen Van Miegroet's work include Alzheimer's disease research and treatments (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Genetic Associations and Epidemiology (2 papers). Helen Van Miegroet is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Genetic Associations and Epidemiology (2 papers). Helen Van Miegroet collaborates with scholars based in Belgium, France and United States. Helen Van Miegroet's co-authors include Els Lierman, Jan Cools, Peter Marynen, Nicole Mentens, Karolien Bettens, Nathalie Brouwers, Kristel Sleegers, Christine Van Broeckhoven, Sebastiaan Engelborghs and Peter Paul De Deyn and has published in prestigious journals such as Blood, Journal of Alzheimer s Disease and Human Mutation.

In The Last Decade

Helen Van Miegroet

8 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Van Miegroet Belgium 8 137 77 74 68 47 8 314
Carla Micucci Italy 9 153 1.1× 133 1.7× 42 0.6× 37 0.5× 91 1.9× 21 422
Xinji Guo United States 9 242 1.8× 52 0.7× 69 0.9× 26 0.4× 12 0.3× 13 386
Sandra Gallagher United States 9 72 0.5× 37 0.5× 27 0.4× 46 0.7× 32 0.7× 11 312
Amy Andreucci United States 7 264 1.9× 92 1.2× 27 0.4× 25 0.4× 16 0.3× 10 388
Alexia Eliades United States 10 184 1.3× 24 0.3× 45 0.6× 149 2.2× 32 0.7× 16 395
Valerie K. Salato United States 8 113 0.8× 32 0.4× 69 0.9× 15 0.2× 12 0.3× 9 334
Binbin Yue United States 10 191 1.4× 59 0.8× 18 0.2× 19 0.3× 55 1.2× 21 324
Guangfen Mao United States 11 132 1.0× 36 0.5× 17 0.2× 229 3.4× 34 0.7× 20 414
Gedeon Loules Greece 11 82 0.6× 46 0.6× 54 0.7× 46 0.7× 10 0.2× 14 383

Countries citing papers authored by Helen Van Miegroet

Since Specialization
Citations

This map shows the geographic impact of Helen Van Miegroet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Van Miegroet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Van Miegroet more than expected).

Fields of papers citing papers by Helen Van Miegroet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Van Miegroet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Van Miegroet. The network helps show where Helen Van Miegroet may publish in the future.

Co-authorship network of co-authors of Helen Van Miegroet

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Van Miegroet. A scholar is included among the top collaborators of Helen Van Miegroet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Van Miegroet. Helen Van Miegroet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bettens, Karolien, Nathalie Brouwers, Helen Van Miegroet, et al.. (2010). Follow-Up Study of Susceptibility Loci for Alzheimer's Disease and Onset Age Identified by Genome-Wide Association. Journal of Alzheimer s Disease. 19(4). 1169–1175. 26 indexed citations
2.
Brouwers, Nathalie, Karolien Bettens, Ilse Gijselinck, et al.. (2010). Contribution of TARDBP to Alzheimer's Disease Genetic Etiology. Journal of Alzheimer s Disease. 21(2). 423–430. 20 indexed citations
3.
Lierman, Els, et al.. (2009). Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen. Haematologica. 94(10). 1440–1444. 13 indexed citations
4.
Sleegers, Kristel, Nathalie Brouwers, Karolien Bettens, et al.. (2009). No association betweenCALHM1and risk for Alzheimer dementia in a Belgian population. Human Mutation. 30(4). E570–E574. 17 indexed citations
5.
Bettens, Karolien, Nathalie Brouwers, Sebastiaan Engelborghs, et al.. (2009). APPandBACE1miRNA genetic variability has no major role in risk for Alzheimer disease. Human Mutation. 30(8). 1207–1213. 41 indexed citations
6.
Sleegers, Kristel, Karolien Bettens, Nathalie Brouwers, et al.. (2008). Common variation inGRB-associated Binding Protein 2 (GAB2)and increased risk for Alzheimer dementia. Human Mutation. 30(2). E338–E344. 27 indexed citations
7.
Lierman, Els, Idoya Lahortiga, Helen Van Miegroet, et al.. (2007). The ability of sorafenib to inhibit oncogenic PDGFR  and FLT3 mutants and overcome resistance to other small molecule inhibitors. Haematologica. 92(1). 27–34. 68 indexed citations
8.
Lierman, Els, Cedric Folens, Elizabeth H. Stover, et al.. (2006). Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutant. Blood. 108(4). 1374–1376. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026